MedTech Innovator Asia Pacific LIVE

About MedTech Innovator Asia Pacific LIVE

Webinars to the public are an hour in length and are live-streamed on our YouTube Channel. They will also be recorded and available for later viewing below. Our Cohort receives personalised and closed-door Q&A sessions after each public livestream.

The goal of the MedTech Innovator webinars is to provide the medtech ecosystem and our portfolio companies with feedback from experts and professionals in areas that are specific to the strategic needs outlined in our discussions and surveys. Strategic areas to be covered include: intellectual property, product development, commercialization, reimbursement, healthcare economics, regulatory strategy, clinical trial design and execution, and fundraising.

Our webinars are administered virtually and consist of one or more panelists addressing key questions supplied in advance by the MedTech Innovator Accelerator companies, as well as a general discussion on the topic within the context of the evolving healthcare ecosystem.


Webinar 1 – Perfecting Your Pitch Video

Sarah Cheung (VP of Operations, Opharmic Technology)

Sarah currently oversees the organization and operations of Opharmic Technology, a young medtech company specialised in the development of non-invasive ultrasonic medical platform technology. Skilled in pharmaceutical research and engineering, she was a researcher on drug delivery and formulation at the Chinese University of Hong Kong School of Medicine, and Jacobson’s Pharma Group prior to joining Opharmic. With strong interest in biotechnology and computational science and Sarah has previously founded a UX design and digital marketing firm during her university studies with a holistic clientele ranging from local biotech startups to international hardware companies. Opharmic Technology was the Grand Prize Winner for MedTech Innovator Asia Pacific program in 2021.

Rohan Dixit (CEO & Founder, Lief Therapeutics)

Rohan Dixit is founder and CEO of Lief (getlief.com) a discreet sensor patch that gives you control over your natural stress response. Formerly a Harvard and Stanford neuroscientist, Rohan studied the effect of meditation on the structural and functional properties of the human brain. His companies have helped thousands of American patients decrease stress, anxiety and chronic pain safely and without drugs.


Webinar 2 – Venture Capital (VC) vs Corporate Venture Capital (CVC): Differences & Similarities

Wei Wu (Principal, Venture Investments at Johnson & Johnson)

Wei is a Principal of Johnson&Johnson Innovation- JJDC, the corporate venture group of J&J. She initiates and manages equity investments in biopharma, medical device, and consumer health, to drive innovation and fuel new and sustainable businesses. Prior to joining JJDC, Wei was a Senior Associate at Illumina Ventures with a focus on genomics-enabled precision medicine including therapeutics, diagnostics, and life science tools. Prior to that, she was the Director of Healthcare Investment and Business Development of BOE Ventures where she focused on VC fund investment, direct investment, and business development opportunities at the intersection of technology and life sciences. Before becoming an investor, Wei was a R&D project lead at NuGEN Technologies (later acquired to become TECAN Genomics). Wei received her Ph.D. from UCLA in Biological Chemistry and completed her postdoctoral research in the Department of Pathology at Stanford University. She received a Bachelor of Science in Biological Sciences from Peking University, China.

Joseph Mocanu (Managing Partner, Verge HealthTech Fund)

Joseph is the Managing Partner of Verge HealthTech Fund focusing on early stage healthcare technology companies relevant to emerging markets. Prior to this, Joseph was a scientist researching new cancer therapies, a medical device entrepreneur, and a management consultant for Oliver Wyman where he led life sciences and digital health across Asia. He has 19 scientific publications, 3 patents, and has made investments in 20 healthcare technology companies to date.

Joseph has a PhD from the University of Toronto, and an MBA from the Richard Ivey School of Business.

Alan Goh (CEO at NDR Medical Technology)

Alan Goh is the CEO of NDR Medical Technology, a medtech start-up that develops surgical robotics to assist surgeons during minimally invasive surgery. Driven by Artificial Intelligence and Medical Image Analysis to automate the needle targeting procedure, improves the clinical outcome, reduces radiation exposure and overall operation time. Medical Robotics will ensure surgeons of all experiences to be able to perform complex and high-risk surgery with ease. NDR is conducting clinical trials with various hospitals in Asia.

Graduated from Nanyang Technological University (NTU) with Bachelor of Engineering specializing in Mechatronics; together with a professional Graduate Diploma in medical technology manufacturing and completed courses in Charter Financial Analyst. He started his career in A*Star as a research engineer working on advance test equipment with the industry and was awarded the Outstanding Team Award in 2007 for his outstanding performance. He further advanced his career in the industry on product application, gained in-depth manufacturing experience and received Six-Sigma Green belt. Before starting NDR, he was a commercialization manager responsible for incubating and seeding medtech/biotech startups, developing business plan as well as supporting in medtech product development.


Webinar 3 – Attracting Talent and Building Effective MedTech Advisory Boards

Joe Muldoon (CEO of FAST BioMedical)

Joe Muldoon is the Chief Executive Officer for FAST BioMedical, a privately held, clinical stage medical company currently developing technology for quantifying plasma volume and kidney function. He leverages 27 years of experience, from technology start-ups to publicly traded multi-national companies. He has worked with many high-growth entrepreneurial companies as a Board advisor, investor, and CEO. He previously served as an Entrepreneur in Residence of the Indiana Venture Center and President of Brightpoint North America (NASDAQ:CELL) Mr. Muldoon has a Bachelor of Science in Business from Indiana University’s Kelley School of Business, where he is a frequent panelist and speaker for MBA programs. He serves on the Boards of Confluence Pharmaceuticals, Heart Reach Carmel and FAST BioMedical. He has previously served on the Boards of TGX Medical, Jameson, Inc., Venture Club of Indiana, and InfoDynamics.

Alex Newton (CEO of Navi Medical Technologies)

Alex is a business leader, aerospace engineer and company director with experience in technical and management roles. He spent the first decade of his career working on projects for Lockheed Martin, Boeing and Airbus in the United States and Australia, before undertaking an MBA at the Melbourne Business School in 2014 to broaden his management skills and experience.

Along with five co-founders (Brad, Christiane, Mubin, Shing & Wei), Alex created Navi Medical Technologies in 2017 to commercialise technology that helps doctors and nurses care for critically ill newborns. Over the last two years Alex has led the company to raise over $2 million of early stage Angel, VC and grant funding to support research and development activities within Navi.

In his spare time Alex is committed to a number of volunteer roles, holding board positions in NFPs Pangea Global Health Education and the Melbourne Space Program, and is an innovation coach for the Melbourne Business School’s Executive Education program.


Webinar 4 – Product Design & Engineering: A Global Perspective

Yan Lin Lye (Head of APAC MedTech, Cambridge Consultants)

Yan Lin is a global citizen with experience building medtech businesses and technologies across Europe, APAC, and North America. An independent thinker and highly self-motivated, Yan Lin is often deployed into opaque and/or dynamic situations to bring clarity and an independent assessment. Using a mixture of analysis techniques, data, and her networks across the industry, Yan Lin defines strategic directions and a tactical responses for her employers and clients. Besides her commercial acumen, Yan Lin has practical experience developing new medical technologies for both developed and developing market applications. She enjoys enabling and accelerating the commercialization process by contributing her experience, knowledge, and network to product teams with the ultimate goal of bringing life saving technologies to patients as quickly as possible.

Rahul Sathe (Vice President Surgical Innovation at Cambridge Consultants)

Rahul leads Cambridge Consultants global medical device business. Our teams help clients transform the future of surgery by developing smart implants, robotics & navigation systems, advanced critical care equipment, and digital surgery platforms.

Rahul’s passion is leading teams to combine business strategy, clinical science, and advanced technology to address unmet needs of patients, surgical teams, and hospitals in global markets. He has led over 30 complex programs across strategy, M&A, R&D, and manufacturing for multiple Class II and III medical devices. He has deep domain expertise in laparoscopy, endoscopy, surgical robotics, neurostimulation, cardiac rhythm management, surgical oncology, colorectal, bariatric, orthopedics, and cardiovascular products.

Langston Suen (CEO & Founder of Opharmic Technology)

Dr. Langston Suen is the CEO and founder of Opharmic Technology. Founded in 2016, Opharmic is striving towards an ambitious goal: to replace horrifying eye injections around the world with our patented non-invasive ultrasound system. Based on over a decade of research and development, the team has successfully developed extensive drug delivery applications in the ophthalmology space. From technology and product customisation, to clinical development and regulatory strategies, Opharmic offers turnkey solution to pharma partners around the world to adopt cutting-edge technology in their new or existing pipelines.

Langston holds a Masters Degree in Chemical Engineering and a Ph.D in Chemical Engineering and Nanotechnology, both from the Hong Kong University of Science and Technology.


Webinar 5 – Manufacturing & Supply Chain Management

Speaker TBC


Webinar 6 – Clinical Trial Management in MedTech & Working with CROs

Speaker TBC


Webinar 7 – Regulatory Strategy: U.S. vs APAC

Speaker TBC


Webinar 8 – Healtheconomics & Communicating Value

Speaker TBC


Webinar 9 – Building an Intellectual Property Portfolio

Speaker TBC


Webinar 10 – Commercialization: Building & Managing Distribution Channels in APAC vs U.S.

2022 Schedule

All webinars begin at 10:00AM SGT, unless otherwise noted

Deprecated: Non-static method CCS_Loop::shortcode_comment() should not be called statically in /nas/content/live/mtinnovator/wp-includes/shortcodes.php on line 356

Warning: Invalid argument supplied for foreach() in /nas/content/live/mtinnovator/wp-content/themes/finanza/include/function/gdlr-page-item.php on line 127

Manufacturing & Supply Chain Management